168 related articles for article (PubMed ID: 22728258)
1. Chemokines at mucosal barriers and their impact on HIV infection.
Rancez M; Couëdel-Courteille A; Cheynier R
Cytokine Growth Factor Rev; 2012; 23(4-5):233-43. PubMed ID: 22728258
[TBL] [Abstract][Full Text] [Related]
2. Mucosal immunity in HIV infection: what can be done to restore gastrointestinal-associated lymphoid tissue function?
George MD; Asmuth DM
Curr Opin Infect Dis; 2014 Jun; 27(3):275-81. PubMed ID: 24739345
[TBL] [Abstract][Full Text] [Related]
3. The mucosal immune system and HIV-1 infection.
Veazey R; Lackner A
AIDS Rev; 2003; 5(4):245-52. PubMed ID: 15012003
[TBL] [Abstract][Full Text] [Related]
4. Macrophages accumulate in the gut mucosa of untreated HIV-infected patients.
Allers K; Fehr M; Conrad K; Epple HJ; Schürmann D; Geelhaar-Karsch A; Schinnerling K; Moos V; Schneider T
J Infect Dis; 2014 Mar; 209(5):739-48. PubMed ID: 24133185
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1.
Grivel JC; Elliott J; Lisco A; Biancotto A; Condack C; Shattock RJ; McGowan I; Margolis L; Anton P
AIDS; 2007 Jun; 21(10):1263-72. PubMed ID: 17545702
[TBL] [Abstract][Full Text] [Related]
6. Selective generation of gut-tropic T cells in gut-associated lymphoid tissues: requirement for GALT dendritic cells and adjuvant.
Svensson M; Johansson-Lindbom B; Wurbel MA; Malissen B; Márquez G; Agace W
Ann N Y Acad Sci; 2004 Dec; 1029():405-7. PubMed ID: 15681793
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal immune responses in HIV infected subjects.
Castello-Branco LR; Lewis DJ; Ortigõ-de-Sampaio MB; Griffin GE
Mem Inst Oswaldo Cruz; 1996; 91(3):363-6. PubMed ID: 9040857
[TBL] [Abstract][Full Text] [Related]
8. Function of mucosa-associated lymphoid tissue in antibody formation.
Brandtzaeg P
Immunol Invest; 2010; 39(4-5):303-55. PubMed ID: 20450282
[TBL] [Abstract][Full Text] [Related]
9. HIV persistence: chemokines and their signalling pathways.
Evans VA; Khoury G; Saleh S; Cameron PU; Lewin SR
Cytokine Growth Factor Rev; 2012; 23(4-5):151-7. PubMed ID: 22749173
[TBL] [Abstract][Full Text] [Related]
10. Plasma-cell homing.
Kunkel EJ; Butcher EC
Nat Rev Immunol; 2003 Oct; 3(10):822-9. PubMed ID: 14523388
[TBL] [Abstract][Full Text] [Related]
11. CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides.
Jiang JQ; Patrick A; Moss RB; Rosenthal KL
J Virol; 2005 Jan; 79(1):393-400. PubMed ID: 15596832
[TBL] [Abstract][Full Text] [Related]
12. Humoral immune responses to the human immunodeficiency virus type-1 (HIV-1) in the genital tract compared to other mucosal sites.
Mestecky J
J Reprod Immunol; 2006 Dec; 72(1-2):1-17. PubMed ID: 17095369
[TBL] [Abstract][Full Text] [Related]
13. GALT: organization and dynamics leading to IgA synthesis.
Suzuki K; Kawamoto S; Maruya M; Fagarasan S
Adv Immunol; 2010; 107():153-85. PubMed ID: 21034974
[TBL] [Abstract][Full Text] [Related]
14. Th17 cells, HIV and the gut mucosal barrier.
Dandekar S; George MD; Bäumler AJ
Curr Opin HIV AIDS; 2010 Mar; 5(2):173-8. PubMed ID: 20543596
[TBL] [Abstract][Full Text] [Related]
15. Mucosal immunization with inactivated human immunodeficiency virus plus CpG oligodeoxynucleotides induces genital immune responses and protection against intravaginal challenge.
Dumais N; Patrick A; Moss RB; Davis HL; Rosenthal KL
J Infect Dis; 2002 Oct; 186(8):1098-105. PubMed ID: 12355360
[TBL] [Abstract][Full Text] [Related]
16. HIV infection and specific mucosal immunity: workshop 4B.
Challacombe SJ; Fidel PL; Tugizov S; Tao L; Wahl SM
Adv Dent Res; 2011 Apr; 23(1):142-51. PubMed ID: 21441496
[TBL] [Abstract][Full Text] [Related]
17. Whole body positron emission tomography imaging of activated lymphoid tissues during acute simian-human immunodeficiency virus 89.6PD infection in rhesus macaques.
Wallace M; Pyzalski R; Horejsh D; Brown C; Djavani M; Lu Y; Hanson JM; Mitchen JL; Perlman SB; Pauza CD
Virology; 2000 Sep; 274(2):255-61. PubMed ID: 10964769
[TBL] [Abstract][Full Text] [Related]
18. Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells.
Bomsel M; Pastori C; Tudor D; Alberti C; Garcia S; Ferrari D; Lazzarin A; Lopalco L
AIDS; 2007 Jan; 21(1):13-22. PubMed ID: 17148963
[TBL] [Abstract][Full Text] [Related]
19. The effect of route of immunization on mucosal immunity and protection.
Lehner T; Wang Y; Ping L; Bergmeier L; Mitchell E; Cranage M; Hall G; Dennis M; Cook N; Doyle C; Jones I
J Infect Dis; 1999 May; 179 Suppl 3():S489-92. PubMed ID: 10099126
[TBL] [Abstract][Full Text] [Related]
20. Characterization of HIV-1-specific cytotoxic T lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue of HIV-1-infected subjects.
Shacklett BL; Beadle TJ; Pacheco PA; Grendell JH; Haslett PA; King AS; Ogg GS; Basuk PM; Nixon DF
Virology; 2000 May; 270(2):317-27. PubMed ID: 10792991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
